Microbot Medical Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Microbot Medical Inc. (NASDAQ: MBOT) on June 5, 2025. The report discloses a material event regarding the company's inclusion in a major market index.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on a corporate governance and market listing event.
Material Changes
Microbot Medical Inc. announced its selection for inclusion in the preliminary list of additions to the Russell Microcap Index, as published by FTSE Russell on May 23, 2025. The reconstituted indexes are scheduled to take effect after the U.S. market close on June 27, 2025, and will be part of the 2025 Russell indexes reconstitution when the market opens on June 30, 2025.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of specific risks and contingencies beyond the standard disclaimer that the information is furnished and not "filed" under Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the final inclusion of Microbot Medical Inc. in the Russell Microcap Index effective June 30, 2025.
- Review the full text of the press release (Exhibit 99.1) for any additional details on the selection criteria.
- Monitor potential changes in trading volume or liquidity resulting from index inclusion.
- Confirm the company's current market capitalization status relative to the Russell Microcap Index requirements.